PRPO logo.png
Precipio Launches HemeScreen® Anemia Panel, a One-of-its-Kind Testing Tool
June 08, 2021 10:30 ET | Precipio, Inc.
 Laboratories can use this rapid, cost effective test to distinguish malignancy-driven anemia from other causes NEW HAVEN, Conn., June 08, 2021 (GLOBE NEWSWIRE) -- Specialty diagnostics company...
PDS Biotech Logo.png
CORRECTING AND REPLACING -- PDS Biotech Announces Release of Interim Data for PDS0101 in NCI-Led Phase 2 Clinical Study in Oral Presentation at ASCO 2021 Annual Meeting
June 08, 2021 07:54 ET | PDS Biotechnology Corporation
FLORHAM PARK, N.J., June 08, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline earlier today by PDS Biotechnology Corporation (Nasdaq: PDSB), we've been informed by the company,...
PDS Biotech Logo.png
PDS Biotech Announces Release of Interim Data for PDS0101 in NCI-Led Phase 2 Clinical Study in Oral Presentation at ASCO 2021 Annual Meeting
June 08, 2021 06:00 ET | PDS Biotechnology Corporation
FLORHAM PARK, N.J., June 08, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s...
gmi logo.jpg
Monoclonal Antibodies Market revenue to cross USD 380 Bn by 2027: Global Market Insights Inc.
June 08, 2021 04:00 ET | Global Market Insights, Inc
Selbyville, Delaware, June 08, 2021 (GLOBE NEWSWIRE) -- According to latest report “Monoclonal Antibodies Market by Type (Fully Human, Humanized, Chimeric), Application (Oncology, Autoimmune...
AB Science is providing a summary of the live webcast held on June 3, 2021 following the voluntary hold in the clinical studies of masitinib
June 08, 2021 02:30 ET | AB Science
PRESS RELEASE SUMMARY OF THE WEBCAST HELD ON JUNE 3, 2021 FOLLOWING THE VOLUNTARY HOLD IN THE CLINICAL STUDIES OF MASITINIB RESUMPTION OF TRADING ON WEDNESDAY JUNE 9, 2021 Paris, June 8, 2021,...
AB Science fournit le résumé de la conférence virtuelle qui s’est tenue le 3 juin 2021 suite à l’interruption volontaire des études cliniques du masitinib
June 08, 2021 02:30 ET | AB Science
COMMUNIQUE DE PRESSE RESUME DE LA CONFERENCE VIRTUELLE DU 3 JUIN 2021 SUITE A L’INTERRUPTION VOLONTAIRE DES ETUDES CLINIQUES DU MASITINIB REPRISE DE LA COTATION MERCREDI 9 JUIN 2021 Paris, 8 juin...
PDS Biotech Logo.png
PDS Biotechnology Set to Join Russell Microcap® Index
June 07, 2021 08:00 ET | PDS Biotechnology Corporation
FLORHAM PARK, N.J., June 07, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing novel cancer therapies based on the Company’s...
American Oncology Network Physicians Research to be Well Represented at the ASCO21 Virtual Scientific Program
June 07, 2021 07:00 ET | American Oncology Network
Fort Myers, Fla., June 07, 2021 (GLOBE NEWSWIRE) -- American Oncology Network, LLC (AON) is pleased to announce that 12 research studies co-authored by AON physicians will be presented at the...
Philips and Elekta deepen strategic partnership in precise and individualized oncology care  
June 07, 2021 02:30 ET | Royal Philips
June 7, 2021Healthcare leaders partner to streamline the path from cancer diagnosis to survivorship for better outcomes Amsterdam, the Netherlands, and Stockholm, Sweden – Royal Philips...
15-SORRENTO-Therapeutics-Logo-FINAL.png
Sorrento Announces Positive Results From Its License Partner, Kelun, on a Phase I Study of Safety and Pharmacokinetics of A166, a Novel HER2 ADC for Advanced HER2 Positive Breast Cancers
June 04, 2021 15:13 ET | Sorrento Therapeutics, Inc.
A166 (ASCO Abstract #1024) is a third generation antibody drug conjugate (ADC) against HER2-positive breast cancer with Levena’s proprietary tubulin inhibitor Duo-5 toxin, cleavable linker and...